Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5IZC

Trypanosoma brucei PTR1 in complex with inhibitor F032

Summary for 5IZC
Entry DOI10.2210/pdb5izc/pdb
DescriptorPteridine reductase, NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, N~2~-[(thiophen-2-yl)methyl]-1,3,4-thiadiazole-2,5-diamine, ... (7 entities in total)
Functional Keywordstrypanosoma brucei, pteridine reductase, inhibitor, oxidoreductase
Biological sourceTrypanosoma brucei brucei
More
Total number of polymer chains4
Total formula weight118438.26
Authors
Pozzi, C.,Landi, G.,Di Pisa, F.,Mangani, S. (deposition date: 2016-03-25, release date: 2017-04-05, Last modification date: 2024-01-10)
Primary citationLinciano, P.,Dawson, A.,Pohner, I.,Costa, D.M.,Sa, M.S.,Cordeiro-da-Silva, A.,Luciani, R.,Gul, S.,Witt, G.,Ellinger, B.,Kuzikov, M.,Gribbon, P.,Reinshagen, J.,Wolf, M.,Behrens, B.,Hannaert, V.,Michels, P.A.M.,Nerini, E.,Pozzi, C.,di Pisa, F.,Landi, G.,Santarem, N.,Ferrari, S.,Saxena, P.,Lazzari, S.,Cannazza, G.,Freitas-Junior, L.H.,Moraes, C.B.,Pascoalino, B.S.,Alcantara, L.M.,Bertolacini, C.P.,Fontana, V.,Wittig, U.,Muller, W.,Wade, R.C.,Hunter, W.N.,Mangani, S.,Costantino, L.,Costi, M.P.
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery.
ACS Omega, 2:5666-5683, 2017
Cited by
PubMed Abstract: Pteridine reductase-1 (PTR1) is a promising drug target for the treatment of trypanosomiasis. We investigated the potential of a previously identified class of thiadiazole inhibitors of PTR1 for activity against (). We solved crystal structures of several PTR1-inhibitor complexes to guide the structure-based design of new thiadiazole derivatives. Subsequent synthesis and enzyme- and cell-based assays confirm new, mid-micromolar inhibitors of PTR1 with low toxicity. In particular, compound , a biphenyl-thiadiazole-2,5-diamine with IC = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC value. In addition, the antiparasitic activity of the combination of and MTX was reversed by addition of folic acid. By adopting an efficient hit discovery platform, we demonstrate, using the 2-amino-1,3,4-thiadiazole scaffold, how a promising tool for the development of anti- agents can be obtained.
PubMed: 28983525
DOI: 10.1021/acsomega.7b00473
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.92 Å)
Structure validation

237735

건을2025-06-18부터공개중

PDB statisticsPDBj update infoContact PDBjnumon